Abstract
Bleeding and thrombus formation are common problems with life-threatening implications in patients receiving a left ventricular assist device. We describe the anticoagulation protocol for the 1st patient in the United States to undergo successful implantation of the Heart/Mate® II left ventricular assist system.
| Original language | English |
|---|---|
| Pages (from-to) | 399-401 |
| Number of pages | 3 |
| Journal | Texas Heart Institute Journal |
| Volume | 32 |
| Issue number | 3 |
| State | Published - 2005 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Activated partial thromboplastin time
- Anticoagulants/administration and dosage
- Blood coagulation tests
- Cardiac surgical procedures
- Heart-assist devices
- Human
- Male
- Monitoring, physiologic/instrumentation
- Platelet function tests
- Prothrombin time
Fingerprint
Dive into the research topics of 'A successful anticoagulation protocol for the first HeartMate® II implantation in the United States'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver